A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

Clinical trial NCT05415462 · COMPLETED

Trial details

NCT number: NCT05415462
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Seasonal Influenza

Start date: 2022-06-06
Primary completion: 2023-09-04
Enrollment: 6102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.